Related Experiment Video
Updated: Aug 1, 2025

07:34
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
717
Precision medicine for prostate cancer-improved outcome prediction for low-intermediate risk disease using a six-gene
William Lautert-Dutra1, Rodolfo Borges Dos Reis2, Jeremy A Squire3,4
1Department of Genetics, Medicine School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
British Journal of Cancer
|April 29, 2023
Abstract:
A multiplex 6-gene copy number classifier was used to distinguish between low- or intermediate-risk prostate cancer patients. The study analysed a cohort of 448 patients and previously published datasets from radical prostatectomies. The classifier performs better than conventional stratification methods, is low cost, and can be performed easily in clinical laboratories.

